Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
28 Oct 2024
More Patients in the East to Benefit from Personalised Breast Cancer Treatment
A pioneering breast cancer initiative is set to expand to Norfolk and Norwich University Hospital, providing more patients in the East with access to advanced, tailored treatment.
28 Oct 2024
Immune Therapy Shows Cancer-Free Survival For 10 Years
Nearly half of patients with metastatic melanoma treated with a combination of the immune checkpoint inhibitors nivolumab and ipilimumab have survived cancer-free, underscoring the impact of immunotherapy in advanced melanoma.
28 Oct 2024
New Model Detects Liver Cancer Risk in Noncirrhotic Patients with Hepatitis B
A newly developed prognostic model predicts liver cancer risk in patients with hepatitis B without cirrhosis, identifying a nonlinear relationship between viral load and cancer risk
28 Oct 2024
Duloxetine Recalled Due to Cancer Risks
Duloxetine, a widely used and popular antidepressant, has been recalled by U.S. Food and Drug Administration (FDA) due to the detection of N-nitroso-duloxetine, a chemical suspected of being carcinogenic.
27 Oct 2024
Arm Position Significantly Impacts Blood Pressure Readings
New research has shown that nonstandard arm positions during blood pressure measurements significantly overestimate systolic and diastolic BP
27 Oct 2024
Optimal Treatment Strategies for Sjögren's Disease-Associated Lymphoma Revealed
A new study has highlighted the optimal treatment strategies for managing non-Hodgkin lymphoma in patients with Sjögren’s disease
27 Oct 2024
Chronic Pain Progresses 1 Year After Whiplash Injury
Hippocampal functional connectivity may be an early indicator of chronic pain development in patients following whiplash and mild traumatic brain injuries (mTBIs) according to the results of a new study.
27 Oct 2024
The Surprising Impact of Hot Temperatures on Raynaud’s Disease
The severity of Raynaud’s disease is not only linked to very low temperatures, but also hot environments that reach 35°C and above, according to recent research.
26 Oct 2024
Ultrasound Method Can Detect Cellular Rejection in Liver Transplant Cases
A new ultrasound measurement technique has the potential to help detect and stage acute cellular rejection in liver transplant patients, recent research has revealed
26 Oct 2024
Tusi: Mysterious New Drug Trend Rising
Tusi, a new drug blend also known as “pink cocaine,” is gaining traction across Latin America, Europe, and more recently, in the United States.
←
1
2
3
…
30
31
32
33
34
35
36
…
920
921
922
→